Stock listing
Mbx Biosciences, Inc.
Selected listing: MBX · NASDAQ · USD · US
Mbx Biosciences, Inc. (NASDAQ:MBX), Health Technology. Latest release Sep 8, 2026: MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer.
- Ticker
- NASDAQ:MBX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Mbx Biosciences, Inc.
Mbx Biosciences, Inc. is a publicly traded company listed under the ticker MBX in the American market. Mbx Biosciences focuses on developing innovative solutions in the biosciences sector.
Latest news from Mbx Biosciences, Inc.
MBX Biosciences Announces Appointment of Jeff Held as Chief Legal Officer
September 8, 2026
MBX Biosciences Announces First Patient Dosed in Pivotal Phase 3 oPTimize Trial of Once-Weekly Canvuparatide in Adults with Hypoparathyroidism
August 27, 2026
MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 6, 2026
MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth
July 13, 2026
MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism
June 12, 2026
Events
Research Mbx Biosciences, Inc.
Mbx Biosciences, Inc. company profile
View the public company page for Mbx Biosciences, Inc. on 6ix.
Mbx Biosciences, Inc. news
Read company news and market updates connected to Mbx Biosciences, Inc..
Mbx Biosciences, Inc. investor events
Find investor webinars, events, and replay context for Mbx Biosciences, Inc..